Correlation Between Alto Neuroscience, and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Alto Neuroscience, and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Crinetics Pharmaceuticals.
Diversification Opportunities for Alto Neuroscience, and Crinetics Pharmaceuticals
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alto and Crinetics is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, Alto Neuroscience, is 4.19 times more volatile than Crinetics Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest 5,202 in Crinetics Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 518.00 from holding Crinetics Pharmaceuticals or generate 9.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alto Neuroscience, vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Alto Neuroscience, |
| Crinetics Pharmaceuticals |
Alto Neuroscience, and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and Crinetics Pharmaceuticals
The main advantage of trading using opposite Alto Neuroscience, and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Alto Neuroscience, vs. Crinetics Pharmaceuticals | Alto Neuroscience, vs. Enanta Pharmaceuticals | Alto Neuroscience, vs. Amicus Therapeutics | Alto Neuroscience, vs. Connect Biopharma Holdings |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |